Breaking News Instant updates and real-time market news.

GSK

GlaxoSmithKline

$39.86 /

+0.78 (+2.00%)

06:04
06/24/21
06/24
06:04
06/24/21
06:04

Deutsche Bank upgrades GSK to Hold on 'obviously improving' story

Deutsche Bank analyst Emmanuel Papadakis last night upgraded GlaxoSmithKline to Hold from Sell with a price target of 1,350 GBp, up from 1,300 GBp. The company yesterday offered a set of "reasonably credible guidances" that modestly surprised on the upside, Papadakis tells investors in a research note. Guidance execution and an "obviously improving" operational story in the second half of 2021 "diminishes the grounds for remaining explicitly cautious in the short-term," says the anlayst.

GSK GlaxoSmithKline
$39.86 /

+0.78 (+2.00%)

06/23/21 Deutsche Bank
GlaxoSmithKline upgraded to Hold from Sell at Deutsche Bank
06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler

TODAY'S FREE FLY STORIES

Earnings
Commerce Bancshares reports Q3 EPS $1.05, consensus 99c » 06:00
10/19/21
10/19
06:00
10/19/21
06:00
CBSH

Commerce Bancshares

$71.59 /

+0.215 (+0.30%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CBSH Commerce Bancshares
$71.59 /

+0.215 (+0.30%)

CBSH Commerce Bancshares
$71.59 /

+0.215 (+0.30%)

10/11/21 Jefferies
Commerce Bancshares price target lowered to $67 from $75 at Jefferies
04/16/21 BofA
Commerce Bancshares downgraded to Underperform from Neutral at BofA
10/21/20 Raymond James
Commerce Bancshares upgraded to Market Perform from Underperform at Raymond James
10/21/20 BofA
Commerce Bancshares upgraded to Neutral from Underperform at BofA
CBSH Commerce Bancshares
$71.59 /

+0.215 (+0.30%)

Downgrade
UCB downgraded to Equal Weight from Overweight at Barclays » 06:00
10/19/21
10/19
06:00
10/19/21
06:00
UCBJY

UCB

$57.45 /

+0.715 (+1.26%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UCBJY UCB
$57.45 /

+0.715 (+1.26%)

09/16/21 Jefferies
UCB upgraded to Buy from Hold at Jefferies
09/02/21 Barclays
UCB price target raised to EUR 102 from EUR 100 at Barclays
09/02/21 JPMorgan
UCB upgraded to Overweight from Neutral at JPMorgan
08/23/21 UBS
UCB upgraded to Buy from Neutral at UBS
General news
Oil Action: » 06:00
10/19/21
10/19
06:00
10/19/21
06:00
$ECON

Economic Data

/

+

Oil Action: The front end…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Upgrade
Merck KGaA upgraded to Overweight from Equal Weight at Barclays » 05:59
10/19/21
10/19
05:59
10/19/21
05:59
MKGAY

Merck KGaA

$38.36 /

+ (+0.00%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MKGAY Merck KGaA
$38.36 /

+ (+0.00%)

MKGAY Merck KGaA
$38.36 /

+ (+0.00%)

09/14/21 UBS
Merck KGaA downgraded to Sell from Neutral at UBS
07/09/21 DZ Bank
Merck KGaA downgraded to Hold from Buy at DZ Bank
04/14/21 HSBC
Merck KGaA downgraded to Reduce from Hold at HSBC on valuation
04/14/21 HSBC
Merck KGaA downgraded to Reduce from Hold at HSBC
MKGAY Merck KGaA
$38.36 /

+ (+0.00%)

Downgrade
Ipsen downgraded to Underweight from Overweight at Barclays » 05:59
10/19/21
10/19
05:59
10/19/21
05:59
IPSEY

Ipsen

$25.06 /

+ (+0.00%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IPSEY Ipsen
$25.06 /

+ (+0.00%)

IPSEY Ipsen
$25.06 /

+ (+0.00%)

05:12 Today Exane BNP Paribas
Ipsen initiated with a Neutral at Exane BNP Paribas
10/11/21 JPMorgan
Ipsen price target raised to EUR 100 from EUR 95 at JPMorgan
10/07/21 Morgan Stanley
Ipsen price target raised to EUR 90 from EUR 88 at Morgan Stanley
08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
Upgrade
Shell Midstream upgraded to Overweight from Equal Weight at Barclays » 05:58
10/19/21
10/19
05:58
10/19/21
05:58
SHLX

Shell Midstream

$11.81 /

+0.13 (+1.11%)

Barclays analyst Theresa…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHLX Shell Midstream
$11.81 /

+0.13 (+1.11%)

SHLX Shell Midstream
$11.81 /

+0.13 (+1.11%)

10/15/21 Credit Suisse
Shell Midstream upgraded to Neutral from Underperform at Credit Suisse
09/28/21 BofA
BofA reinstates coverage of U.S. Midstream sector with six buys, four sells
09/28/21 BofA
Shell Midstream initiated with an Underperform at BofA
08/02/21 JPMorgan
Shell Midstream assumed with an Underweight at JPMorgan
SHLX Shell Midstream
$11.81 /

+0.13 (+1.11%)

Downgrade
Holly Energy Partners downgraded to Equal Weight from Overweight at Barclays » 05:57
10/19/21
10/19
05:57
10/19/21
05:57
HEP

Holly Energy Partners

$20.06 /

+0.05 (+0.25%)

Barclays analyst Theresa…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HEP Holly Energy Partners
$20.06 /

+0.05 (+0.25%)

HEP Holly Energy Partners
$20.06 /

+0.05 (+0.25%)

08/04/21 JPMorgan
Holly Energy Partners downgraded to Underweight from Neutral at JPMorgan
08/02/21 JPMorgan
Holly Energy Partners assumed with a Neutral at JPMorgan
05/13/21 Wells Fargo
Holly Energy Partners downgraded to Equal Weight from Overweight at Wells Fargo
04/27/21 JPMorgan
Holly Energy Partners downgraded to Neutral from Overweight at JPMorgan
HEP Holly Energy Partners
$20.06 /

+0.05 (+0.25%)

Downgrade
Grifols downgraded to Underweight from Overweight at Barclays » 05:57
10/19/21
10/19
05:57
10/19/21
05:57
GRFS

Grifols

$13.79 /

-0.42 (-2.96%)

Barclays analyst Rosie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRFS Grifols
$13.79 /

-0.42 (-2.96%)

GRFS Grifols
$13.79 /

-0.42 (-2.96%)

10/06/21 Citi
Grifols upgraded to Buy from Neutral at Citi
08/04/21 Credit Suisse
Grifols price target raised to EUR 27 from EUR 25 at Credit Suisse
08/04/21 Deutsche Bank
Grifols price target lowered to EUR 27 from EUR 30 at Deutsche Bank
06/30/21 Barclays
Grifols price target raised to EUR 28.40 from EUR 28 at Barclays
Upgrade
Argenx upgraded to Overweight from Equal Weight at Barclays » 05:56
10/19/21
10/19
05:56
10/19/21
05:56
ARGX

Argenx

$292.19 /

-1.85 (-0.63%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARGX Argenx
$292.19 /

-1.85 (-0.63%)

ARGX Argenx
$292.19 /

-1.85 (-0.63%)

10/06/21 Jefferies
Argenx initiated with a Buy at Jefferies
10/04/21 Baird
Argenx price target raised to $355 from $333 at Baird
09/23/21 Redburn
Argenx upgraded to Buy into efgartigimod readouts at Redburn
09/23/21 Redburn
Argenx upgraded to Buy from Neutral at Redburn
ARGX Argenx
$292.19 /

-1.85 (-0.63%)

  • 03
    Feb
Upgrade
Pearson upgraded to Neutral from Underperform at Credit Suisse » 05:55
10/19/21
10/19
05:55
10/19/21
05:55
PSO

Pearson

$8.51 /

-0.11 (-1.28%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PSO Pearson
$8.51 /

-0.11 (-1.28%)

PSO Pearson
$8.51 /

-0.11 (-1.28%)

05:09 Today Berenberg
Pearson upgraded to Hold from Sell at Berenberg
10/18/21 Barclays
Pearson price target lowered to 585 GBp from 660 GBp at Barclays
10/18/21 JPMorgan
Pearson price target lowered to 930 GBp from 960 GBp at JPMorgan
10/08/21 Barclays
Pearson price target lowered to 660 GBp from 775 GBp at Barclays
PSO Pearson
$8.51 /

-0.11 (-1.28%)

PSO Pearson
$8.51 /

-0.11 (-1.28%)

PSO Pearson
$8.51 /

-0.11 (-1.28%)

Initiation
Naked Wines initiated with a Hold at Berenberg » 05:53
10/19/21
10/19
05:53
10/19/21
05:53
NWINF

Naked Wines

$9.35 /

-0.225 (-2.35%)

Berenberg analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NWINF Naked Wines
$9.35 /

-0.225 (-2.35%)

09/20/21 Liberum
Naked Wines downgraded to Sell from Hold at Liberum
Initiation
Shiseido initiated with an Outperform at Bernstein » 05:51
10/19/21
10/19
05:51
10/19/21
05:51
SSDOY

Shiseido

$65.96 /

-0.93 (-1.39%)

Bernstein analyst Melinda…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSDOY Shiseido
$65.96 /

-0.93 (-1.39%)

09/10/21 Goldman Sachs
Shiseido upgraded to Buy from Neutral at Goldman Sachs
03/31/21 CLSA
Shiseido upgraded to Buy from Outperform at CLSA
11/11/20 Daiwa
Shiseido upgraded to Neutral from Underperform at Daiwa
Downgrade
Williams downgraded to Peer Perform from Outperform at Wolfe Research » 05:49
10/19/21
10/19
05:49
10/19/21
05:49
WMB

Williams

$29.29 /

-0.26 (-0.88%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WMB Williams
$29.29 /

-0.26 (-0.88%)

WMB Williams
$29.29 /

-0.26 (-0.88%)

09/28/21 BofA
BofA reinstates coverage of U.S. Midstream sector with six buys, four sells
09/28/21 BofA
Williams reinstated with a Buy at BofA
05/17/21 Argus
Williams upgraded to Buy from Hold at Argus
05/17/21 Argus
Williams upgraded to Buy from Hold at Argus
WMB Williams
$29.29 /

-0.26 (-0.88%)

WMB Williams
$29.29 /

-0.26 (-0.88%)

Downgrade
Enterprise Products downgraded to Peer Perform at Wolfe Research » 05:48
10/19/21
10/19
05:48
10/19/21
05:48
EPD

Enterprise Products

$24.58 /

+0.34 (+1.40%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EPD Enterprise Products
$24.58 /

+0.34 (+1.40%)

EPD Enterprise Products
$24.58 /

+0.34 (+1.40%)

10/05/21 Mizuho
Enterprise Products price target raised to $29 from $28 at Mizuho
09/28/21 BofA
BofA reinstates coverage of U.S. Midstream sector with six buys, four sells
09/28/21 BofA
Enterprise Products reinstated with a Buy at BofA
04/06/21 TD Securities
Enterprise Products initiated with a Buy at TD Securities
EPD Enterprise Products
$24.58 /

+0.34 (+1.40%)

EPD Enterprise Products
$24.58 /

+0.34 (+1.40%)

EPD Enterprise Products
$24.58 /

+0.34 (+1.40%)

Downgrade
International Paper downgraded to Neutral from Outperform at Exane BNP Paribas » 05:47
10/19/21
10/19
05:47
10/19/21
05:47
IP

International Paper

$52.86 /

-0.43 (-0.81%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IP International Paper
$52.86 /

-0.43 (-0.81%)

IP International Paper
$52.86 /

-0.43 (-0.81%)

10/13/21 KeyBanc
Containerboard capacity in North America could rise with new mill, says KeyBanc
10/12/21 Truist
Truist starts International Paper at Hold, sees containerboard cycle near peak
10/12/21 Truist
International Paper initiated with a Hold at Truist
09/28/21 UBS
International Paper price target raised to $52 from $47 at UBS
IP International Paper
$52.86 /

-0.43 (-0.81%)

IP International Paper
$52.86 /

-0.43 (-0.81%)

IP International Paper
$52.86 /

-0.43 (-0.81%)

General news
FX Action: USD-JPY has tumbled to a four-day low » 05:30
10/19/21
10/19
05:30
10/19/21
05:30
$ECON

Economic Data

/

+

FX Action: USD-JPY has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Dr. Reddy's receives FDA approval for Lenalidomide capsules ANDA » 05:28
10/19/21
10/19
05:28
10/19/21
05:28
RDY

Dr. Reddy's

$64.65 /

-1.11 (-1.69%)

Dr. Reddy's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDY Dr. Reddy's
$64.65 /

-1.11 (-1.69%)

RDY Dr. Reddy's
$64.65 /

-1.11 (-1.69%)

07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral at Credit Suisse after Q1 report
07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral from Outperform at Credit Suisse
02/03/21 Investec
Dr. Reddy's upgraded to Buy from Hold at Investec
02/02/21 Barclays
Dr. Reddy's upgraded to Overweight from Equal Weight at Barclays
RDY Dr. Reddy's
$64.65 /

-1.11 (-1.69%)

Earnings
Ericsson reports Q3 EPS SEK 1.73 vs. SEK 1.61 last year » 05:24
10/19/21
10/19
05:24
10/19/21
05:24
ERIC

Ericsson

$12.22 /

+0.03 (+0.25%)

Reports Q3 revenue SEK…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ERIC Ericsson
$12.22 /

+0.03 (+0.25%)

ERIC Ericsson
$12.22 /

+0.03 (+0.25%)

10/08/21 Barclays
Ericsson price target raised to SEK 150 from SEK 145 at Barclays
07/21/21 Arete
Ericsson upgraded to Neutral from Sell at Arete
07/20/21 Credit Suisse
Ericsson price target lowered to SEK 133 from SEK 142 at Credit Suisse
07/19/21 Barclays
Ericsson price target lowered to SEK 145 from SEK 150 at Barclays
ERIC Ericsson
$12.22 /

+0.03 (+0.25%)

ERIC Ericsson
$12.22 /

+0.03 (+0.25%)

ERIC Ericsson
$12.22 /

+0.03 (+0.25%)

ERIC Ericsson
$12.22 /

+0.03 (+0.25%)

Hot Stocks
Niu Technologies appoints Fion Zhou as chief financial officer » 05:20
10/19/21
10/19
05:20
10/19/21
05:20
NIU

Niu Technologies

$24.74 /

+0.48 (+1.98%)

Niu Technologies (NIU)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIU Niu Technologies
$24.74 /

+0.48 (+1.98%)

08/09/21 UBS
UBS suspends Niu Technologies rating after initiating with a Sell
08/09/21 UBS
Niu Technologies initiated with a Sell at UBS
06/22/21 Piper Sandler
Electric vehicles will represent 94% of new car sales by 2040, says Piper
04/15/21 Piper Sandler
Niu Technologies price target raised to $47 from $38 at Piper Sandler
Upgrade
Veidekke upgraded to Buy from Hold at DNB Markets » 05:18
10/19/21
10/19
05:18
10/19/21
05:18
VDEKF

Veidekke

/

+

DNB Markets analyst Simen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
B2Gold reports Q3 gold production 310,261 ounces » 05:16
10/19/21
10/19
05:16
10/19/21
05:16
BTG

B2Gold

$3.93 /

-0.015 (-0.38%)

B2Gold announced its gold…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTG B2Gold
$3.93 /

-0.015 (-0.38%)

BTG B2Gold
$3.93 /

-0.015 (-0.38%)

10/05/21 Scotiabank
B2Gold price target lowered to C$9 from C$9.50 at Scotiabank
09/10/21 National Bank
B2Gold price target lowered to C$8 from C$9 at National Bank
08/06/21 National Bank
B2Gold price target lowered to C$9 from C$9.25 at National Bank
07/16/21 National Bank
B2Gold price target lowered to C$9.25 from C$10 at National Bank
BTG B2Gold
$3.93 /

-0.015 (-0.38%)

Upgrade
Xcel Energy upgraded to Equal Weight from Underweight at Morgan Stanley » 05:15
10/19/21
10/19
05:15
10/19/21
05:15
XEL

Xcel Energy

$64.66 /

-1.26 (-1.91%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XEL Xcel Energy
$64.66 /

-1.26 (-1.91%)

XEL Xcel Energy
$64.66 /

-1.26 (-1.91%)

10/12/21 Goldman Sachs
Xcel Energy upgraded to Buy from Neutral at Goldman Sachs
10/01/21 Barclays
Xcel Energy upgraded to Overweight from Equal Weight at Barclays
08/04/21 Mizuho
Xcel Energy price target raised to $70 from $63 at Mizuho
05/25/21 Barclays
Xcel Energy price target raised to $75 from $69 at Barclays
XEL Xcel Energy
$64.66 /

-1.26 (-1.91%)

Upgrade
Eversource upgraded to Equal Weight from Underweight at Morgan Stanley » 05:15
10/19/21
10/19
05:15
10/19/21
05:15
ES

Eversource

$85.41 /

-1.03 (-1.19%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ES Eversource
$85.41 /

-1.03 (-1.19%)

ES Eversource
$85.41 /

-1.03 (-1.19%)

09/16/21 Mizuho
Eversource price target lowered to $82 from $85 at Mizuho
09/09/21
Fly Intel: Top five analyst downgrades
09/09/21 Mizuho
Mizuho downgrades Eversource to sell on 'near-term event risk'
09/09/21 Mizuho
Eversource downgraded to Underperform from Neutral at Mizuho
ES Eversource
$85.41 /

-1.03 (-1.19%)

Downgrade
Kaleido downgraded to Underweight from Equal Weight at Morgan Stanley » 05:15
10/19/21
10/19
05:15
10/19/21
05:15
KLDO

Kaleido Biosciences

$4.85 /

-0.1 (-2.02%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KLDO Kaleido Biosciences
$4.85 /

-0.1 (-2.02%)

KLDO Kaleido Biosciences
$4.85 /

-0.1 (-2.02%)

07/22/21 JMP Securities
Seres trial news 'disappointing,' but an isolated story, says JMP
07/09/21 Chardan
Kaleido Biosciences assumed with a Buy at Chardan
02/09/21 Piper Sandler
Kaleido Biosciences initiated with an Overweight at Piper Sandler
01/14/21 Chardan
Kaleido Biosciences price target raised to $17.50 from $10 at Chardan
KLDO Kaleido Biosciences
$4.85 /

-0.1 (-2.02%)

  • 04
    Feb
Upgrade
Albemarle upgraded to Outperform from Sector Perform at RBC Capital » 05:14
10/19/21
10/19
05:14
10/19/21
05:14
ALB

Albemarle

$236.92 /

+7.95 (+3.47%)

RBC Capital analyst Arun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALB Albemarle
$236.92 /

+7.95 (+3.47%)

ALB Albemarle
$236.92 /

+7.95 (+3.47%)

10/12/21 Mizuho
Albemarle initiated with a Neutral at Mizuho
10/12/21 Citi
Albemarle price target raised to $266 from $262 at Citi
10/04/21 Loop Capital
Albemarle price target raised to $280 from $253 at Loop Capital
09/17/21 HSBC
Albemarle downgraded to Hold from Buy at HSBC
ALB Albemarle
$236.92 /

+7.95 (+3.47%)

  • 04
    Feb
ALB Albemarle
$236.92 /

+7.95 (+3.47%)

ALB Albemarle
$236.92 /

+7.95 (+3.47%)

ALB Albemarle
$236.92 /

+7.95 (+3.47%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.